This topic contains a solution. Click here to go to the answer

Author Question: Perfectly competitive markets will tend to under-allocate resources to nonexclusive public goods ... (Read 142 times)

urbanoutfitters

  • Hero Member
  • *****
  • Posts: 530
Perfectly competitive markets will tend to under-allocate resources to nonexclusive public goods because
 a. these goods are produced under conditions of increasing returns to scale.
 b. no single individual can appropriate the total benefits provided by the purchase of such goods.
  c. these goods are best produced under conditions of monopoly.
 d. no private producer can provide the capital necessary to produce such goods.

Question 2

Left to their own, private markets tend to
 a. under-allocate resources to public goods.
 b. allocate the economically efficient amount of resources to public goods.
  c. over-allocate resources to public goods.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emilymalinowski12

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

b

Answer to Question 2

a




urbanoutfitters

  • Member
  • Posts: 530
Reply 2 on: Jul 1, 2018
Great answer, keep it coming :)


mammy1697

  • Member
  • Posts: 341
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library